SavedAdd your journal

Journals / Cardiovascular surgery and interventions / 2021 / Cilt: 8 - Sayı: 3

Hemoglobin A1c levels do not predict primary arteriovenous fistula failure in hemodialysis patients

Cemal KOCAASLAN
Ebuzer AYDIN
Betül Nur KESER
Feyza KAYA
Verda SANDAL
Ülkü Nur KIRMAN
Muhammet Raşit TUTAL
Pages
139–144
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our study results suggest that diabetes is associated with AVF failure, but it is not an independent risk factor for AVF failure.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: In this study, we aimed to assess whether higher preoperative levels of glycated hemoglobin (HbA1c) could predict primary arteriovenous fistula (AVF) failure and to investigate the effect of diabetes mellitus on primary arteriovenous failure.
📊
Key Findings & Data:Patients and methods: Between July 2018 and August 2019, a total of 127 newly created AVFs in 117 patients (67 males, 50 females; mean age: 62.4±12.2 years; range, 18 to 86 years) who underwent primary AVF operation in our cardiovascular surgery clinic were retrospectively analyzed.
💡
Conclusion & Impact:Conclusion: Our study results suggest that diabetes is associated with AVF failure, but it is not an independent risk factor for AVF failure.
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: In this study, we aimed to assess whether higher preoperative levels of glycated hemoglobin (HbA1c) could predict primary arteriovenous fistula (AVF) failure and to investigate the effect of diabetes mellitus on primary arteriovenous failure. Patients and methods: Between July 2018 and August 2019, a total of 127 newly created AVFs in 117 patients (67 males, 50 females; mean age: 62.4±12.2 years; range, 18 to 86 years) who underwent primary AVF operation in our cardiovascular surgery clinic were retrospectively analyzed. Medical data were obtained from the institutional database. Arteriovenous fistula failure was evaluated during follow-up. Results: Primary AVF failure was seen in 24 (18.9%) patients. Patients with diabetes mellitus had a higher ratio of failure compared to those without (62.5% vs. 38.8%, respectively; p=0.035). After adjustment, diabetes mellitus was not found to be an independent risk factor for AVF failure (p>0.05). There was no significant correlation between HbA1c levels and fistula failure (p>0.05). Conclusion: Our study results suggest that diabetes is associated with AVF failure, but it is not an independent risk factor for AVF failure. Higher HbA1c levels fail to predict AVF failure.

🔖

Cite This Article

KOCAASLAN, C., AYDIN, E., KESER, B. N., KAYA, F., SANDAL, V., KIRMAN, Ü. N., TUTAL, M. R. (2022). Hemoglobin A1c levels do not predict primary arteriovenous fistula failure in hemodialysis patients. Cardiovascular surgery and interventions, Cilt: 8 - Sayı: 3, 139–144. https://ajindex.com/articles/471047

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. National Kidney Foundation. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. Am J Kidney Dis 2012;60:850-86
  2. Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I. Eur Heart J 2013;34:2436-43
  3. Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. Am J Kidney Dis 2020;75(4 Suppl 2):S1- S164
  4. Hu H, Patel S, Hanisch JJ, Santana JM, Hashimoto T, Bai H, et al. Future research directions to improve fistula maturation and reduce access failure. Semin Vasc Surg. 2016;29:153-71
  5. Vassalotti JA, Jennings WC, Beathard GA, Neumann M, Caponi S, Fox CH, et al. Fistula first breakthrough initiative: Targeting catheter last in fistula first. Semin Dial 2012;25:303-10
  6. Konner K, Nonnast-Daniel B, Ritz E. The arteriovenous fistula. J Am Soc Nephrol 2003;14:1669-80
  7. Keser BN, Kirman UN, Kocaaslan C, Aydin E. The association between vascular access type and depressive symptoms in geriatric hemodialysis population. Vascular 2020;28:390-5
  8. Rooijens PP, Tordoir JH, Stijnen T, Burgmans JP, Smet de AA, Yo TI. Radiocephalic wrist arteriovenous fistula for hemodialysis: Meta-analysis indicates a high primary failure rate. Eur J Vasc Endovasc Surg 2004;28:583-9
  9. Huijbregts HJ, Bots ML, Wittens CH, Schrama YC, Moll FL, Blankestijn PJ; CIMINO study group. Hemodialysis arteriovenous fistula patency revisited: Results of a prospective, multicenter initiative. Clin J Am Soc Nephrol 2008;3:714-9
  10. Yan Y, Ye D, Yang L, Ye W, Zhan D, Zhang L, et al. A metaanalysis of the association between diabetic patients and AVF failure in dialysis. Ren Fail 2018;40:379-83
  11. Aronson D, Bloomgarden Z, Rayfield EJ. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol 1996;27:528-35
  12. Afsar B, Elsurer R. The primary arteriovenous fistula failure-a comparison between diabetic and non-diabetic patients: glycemic control matters. Int Urol Nephrol 2012;44:575-81
  13. Wu CC, Wen SC, Yang CW, Pu SY, Tsai KC, Chen JW. Baseline plasma glycemic profiles but not inflammatory biomarkers predict symptomatic restenosis after angioplasty of arteriovenous fistulas in patients with hemodialysis. Atherosclerosis 2010;209:598-600
  14. Singh P, Ariffin Z, Tajri H, Md Idris A, Suryati L, Sofida L. ROGAVF STUDY 2019 - Relationship of HbA1C (GLYCEMIC Control) on outcomes of AV FIS